CompaniesNC Medical Research

NC Medical Research

active

Tokyo, Japan

Founded 2004

Website

About

Advancing novel therapies

Areas of Focus

Categories

Japan

Clinical Trials (40)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

3,768

By Phase

PHASE1: 15PHASE2: 6NA: 9PHASE4: 2PHASE1/PHASE2: 2PHASE2/PHASE3: 1

By Status

COMPLETED: 26UNKNOWN: 5TERMINATED: 4RECRUITING: 2ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1

Clinical Trials Pipeline40 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Today

NCT00544024

Mefloquine Bioequivalence Among 3 Commercially Available Tablets.

Phase: N/A

Role: Collaborator

Start: Mar 31, 2004

Completion: Mar 31, 2007

NCT00198796

Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains

Phase: Phase 1

Role: Collaborator

Start: Sep 30, 2005

Completion: May 30, 2007

NCT00435526

Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I

Phase: Phase 1

Role: Collaborator

Start: Mar 31, 2006

Completion: Oct 31, 2006

NCT00564577

Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17

Phase: Phase 1

Role: Collaborator

Start: Sep 30, 2006

Completion: Jun 13, 2007

NCT00392015

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

Phase: Phase 1/2

Role: Collaborator

Start: Oct 12, 2006

Completion: Sep 25, 2017

NCT00392015

NCT00524004

Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD

Phase: Phase 2

Role: Collaborator

Start: Jan 30, 2007

Completion: Oct 26, 2007

NCT00434798

Campylobacter Jejuni Challenge Model Development: Dose Ranging Study

Phase: Phase 1

Role: Collaborator

Start: Feb 28, 2007

Completion: Oct 31, 2008

NCT00564863

Dose-Finding Study of CS19 Expressing ETEC Challenge Strains

Phase: Phase 1

Role: Collaborator

Start: Sep 30, 2007

Completion: Sep 4, 2008

NCT00678522

The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes

Phase: Phase 4

Role: Collaborator

Start: Sep 30, 2007

Completion: May 31, 2008

NCT01048112

Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection

Phase: Phase 1

Role: Collaborator

Start: Jan 31, 2010

Completion: Sep 30, 2011

NCT01591512

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Phase: N/A

Role: Collaborator

Start: May 31, 2011

Completion: Jul 31, 2012

NCT01502358

Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease

Phase: Phase 1

Role: Collaborator

Start: Dec 31, 2011

Completion: Dec 31, 2013

NCT02857790

Glasgow MRI and Rotablation Study

Phase: N/A

Role: Collaborator

Start: Mar 31, 2012

Completion: Jun 30, 2016

NCT02857790

NCT01524822

The Effects of Chronic Exposure to Low-Level Blasts

Phase: N/A

Role: Collaborator

Start: Jul 30, 2012

Completion: Not specified

NCT01524822

NCT01618591

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Phase: N/A

Role: Collaborator

Start: Sep 30, 2012

Completion: Mar 31, 2016

NCT01618591

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Phase: N/A

Role: Collaborator

Start: Sep 30, 2012

Completion: Mar 31, 2016

NCT01618591

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Phase: N/A

Role: Collaborator

Start: Sep 30, 2012

Completion: Mar 31, 2016

NCT02215707

A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses

Phase: Phase 1

Role: Collaborator

Start: Jun 30, 2014

Completion: Jun 30, 2015

NCT02280044

Efficacy of Rifaximin in Preventing Campylobacteriosis

Phase: Phase 2/3

Role: Collaborator

Start: Oct 31, 2014

Completion: Aug 9, 2016

NCT02388009

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Phase: Phase 1

Role: Collaborator

Start: Feb 28, 2015

Completion: Sep 30, 2015

NCT02498301

Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD

Phase: N/A

Role: Collaborator

Start: Nov 10, 2015

Completion: Dec 31, 2019

NCT02498301

NCT02601716

PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults

Phase: Phase 2

Role: Collaborator

Start: Jan 31, 2016

Completion: Nov 30, 2017

NCT02773446

Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A

Phase: N/A

Role: Collaborator

Start: Apr 30, 2016

Completion: Dec 31, 2016

NCT02788188

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

Phase: Phase 1

Role: Collaborator

Start: May 28, 2016

Completion: Apr 30, 2018

NCT03040687

Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge

Phase: Phase 1

Role: Collaborator

Start: Jan 31, 2017

Completion: Aug 31, 2017

NCT03404674

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

Phase: Phase 1

Role: Collaborator

Start: Jan 16, 2018

Completion: Mar 26, 2019

NCT03576183

Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701

Phase: Phase 2

Role: Collaborator

Start: Jun 4, 2018

Completion: Nov 30, 2018

NCT03341754

Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults

Phase: Phase 1

Role: Collaborator

Start: Sep 15, 2018

Completion: Mar 23, 2020

NCT03762070

Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru

Phase: N/A

Role: Lead Sponsor

Start: Oct 2, 2018

Completion: Apr 30, 2019

NCT03915431

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Phase: Phase 1/2

Role: Lead Sponsor

Start: Feb 27, 2020

Completion: Oct 31, 2028

NCT03915431

NCT04203186

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

Phase: N/A

Role: Collaborator

Start: Mar 31, 2020

Completion: Sep 30, 2021

NCT04794621

Electroceutical Dressing Technology (EDT) Against Wound Microbial Biofilm Infection

Phase: N/A

Role: Collaborator

Start: Jun 3, 2021

Completion: Jul 7, 2023

NCT05046158

Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care

Phase: N/A

Role: Collaborator

Start: Aug 16, 2021

Completion: Dec 31, 2023

NCT04182490

LMN-101 in a Campylobacter Human Challenge Model

Phase: Phase 2

Role: Collaborator

Start: Feb 21, 2022

Completion: Oct 4, 2022

NCT05203744

Escalating Monthly Doses of Tafenoquine in Healthy Volunteers

Phase: Phase 4

Role: Lead Sponsor

Start: May 10, 2022

Completion: Dec 3, 2022

NCT04953754

Melatonin and Vaccine Response, Immunity, and Chronobiology Study

Phase: N/A

Role: Collaborator

Start: Oct 25, 2022

Completion: Jun 30, 2025

NCT05933525

Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model

Phase: Phase 2

Role: Collaborator

Start: May 29, 2023

Completion: Dec 30, 2024

NCT06122870

CampETEC Hyperimmune Bovine Colostrum (HBC)

Phase: Phase 1

Role: Collaborator

Start: Dec 4, 2023

Completion: Jun 4, 2025

NCT04597437

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

Phase: Phase 2

Role: Collaborator

Start: Mar 15, 2024

Completion: Sep 30, 2026

NCT05959616

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Phase: Phase 1

Role: Collaborator

Start: Jan 21, 2025

Completion: Aug 30, 2027

Hover over trial bars to see details

Recent Trials

NCT05959616Collaborator

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

PHASE1Recruiting

70 participants

Started: Jan 21, 2025 · Completed: Aug 30, 2027

NCT04597437Collaborator

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

PHASE2Recruiting

74 participants

Started: Mar 15, 2024 · Completed: Sep 30, 2026

NCT06122870Collaborator

CampETEC Hyperimmune Bovine Colostrum (HBC)

PHASE1Completed

27 participants

Started: Dec 4, 2023 · Completed: Jun 4, 2025

NCT05933525Collaborator

Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model

PHASE2Completed

60 participants

Started: May 29, 2023 · Completed: Dec 30, 2024

NCT04953754Collaborator

Melatonin and Vaccine Response, Immunity, and Chronobiology Study

NAActive, not recruiting

200 participants

Started: Oct 25, 2022 · Completed: Jun 30, 2025

View all 40 trials →

Locations (1)

Headquarters

Tokyo, Japan

Map

Loading map...